Long term outcome after combined modality treatment for anal cancer

Abstract

BackgroundThe aim of the retrospective study was to evaluate the effectiveness and toxicity of radiochemotherapy in patients with squamous cell carcinoma of the anal canal treated at a single institution.Patients and methodsBetween 1/2003 and 9/2010, 84 patients were treated with radical radiochemotherapy at the Institute of Oncology Ljubljana, Slovenia. The treatment consisted of 3-dimensional conformal external beam radiotherapy with concurrent chemotherapy (5-fluorouracil and mytomycin C), followed by brachytherapy or external beam boost. The toxicity of therapy and its effectiveness were assessed.ResultsThe treatment was completed according to the protocol in 79.8% of patients. The median follow-up time of 55 survivors was 53 months (range: 16–105 months). The 5-year locoregional control (LRC), disease-free survival (DFS), disease-specific survival (DSS), overall survival (OS) and colostomy-free survival (CFS) rates were 71%, 68%, 81%, 67% and 85%, respectively. No treatment-related mortality was observed. The most frequent acute side-effect of the treatment was radiodermatitis (grade 3–4 in 58.2% of patients). LENT-SOMA grade 3–4 late radiation side effects were observed in 15 (18%) patients. In patients with brachytherapy boost a trend of less late side effects was observed compared to patients with external beam boost (P=0.066). On multivariate analysis, complete clinical disease response was identified as an independent prognostic factor for LRC, DFS and DSS, the salvage surgery for LRC and DFS, whereas Hb below 120 g/l retained its independent prognostic value for OS.ConclusionsRadiochemotherapy provides an excellent disease control and the survival with preserving anal sphincter function in majority of patients. Surgical salvage with abdominoperineal resection for persistent or recurrent disease has curative potential.

Effects of social support and self‐efficacy on the psychosocial adjustment of Korean ostomy patients

“…1 The early detection of colorectal cancer, the development of various treatment methods, and the establishment of a standardised therapy have all contributed to the increase in the survival rates of colorectal cancer patients. 2 Increased survival rates suggest that the perception of viewing cancer as an incurable disease should be changed, and it should rather be considered a chronic disease that requires sustained care and management. 3 Among the various subtypes of colorectal cancer, stomas are usually formed through ostomy in cases of rectal cancer located closer to the anus.…”

Long-term Oncologic Outcome and Its Relevant Factors in Anal Cancer in Korea: A Nationwide Data Analysis

“…The treatment strategy for anal cancer mainly depends on the histological type. For squamous cell carcinoma, the most common type of anal cancer, chemoradiation therapy has been the standard treatment and has provided considerable outcomes [17]. The 5-year net survival increased during these 30 years from 63.4% to 72.7%.…”

Cancer incidence and mortality in the Greater Poland Region—Analysis of the year 2010 and future trends

“…Cancer registries allow for the follow up of treatment results. 15 Moreover, evaluation of clinical results using cancer registry data is not only limited to a particular institution but instead enables us to perform inter-institutional comparison between oncology hospitals.…”